Your browser doesn't support javascript.
loading
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Steenbruggen, Tessa G; Wolf, Denise M; Campbell, Michael J; Sanders, Joyce; Cornelissen, Sten; Thijssen, Bram; Salgado, Roberto A; Yau, Christina; O-Grady, Nick; Basu, Amrita; Bhaskaran, Rajith; Mittempergher, Lorenza; Hirst, Gillian L; Coppe, Jean-Philippe; Kok, Marleen; Sonke, Gabe S; van 't Veer, Laura J; Horlings, Hugo M.
Afiliación
  • Steenbruggen TG; Department of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands. t.steenbruggen@nki.nl.
  • Wolf DM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA. t.steenbruggen@nki.nl.
  • Campbell MJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Sanders J; Department of Surgery, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Cornelissen S; Department of Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands.
  • Thijssen B; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands.
  • Salgado RA; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands.
  • Yau C; Department of Pathology, GZA-ZNA Hospitals, 2020, Antwerp, Belgium.
  • O-Grady N; Division of Research, Peter Mac Callum Cancer Centre, Melbourne, VIC, 3000, Australia.
  • Basu A; Department of Surgery, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Bhaskaran R; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Mittempergher L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Hirst GL; Research and Development, Agendia N.V, 1043 NT, Amsterdam, North Holland, The Netherlands.
  • Coppe JP; Research and Development, Agendia N.V, 1043 NT, Amsterdam, North Holland, The Netherlands.
  • Kok M; Department of Surgery, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Sonke GS; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA.
  • van 't Veer LJ; Department of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands.
  • Horlings HM; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, North Holland, The Netherlands.
Breast Cancer Res ; 25(1): 117, 2023 10 04.
Article en En | MEDLINE | ID: mdl-37794508
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido